Mink Other Operating Expenses vs Income Before Tax Analysis
| INKT Stock | USD 0.72 0.03 4.35% |
Mink Therapeutics financial indicator trend analysis is infinitely more than just investigating Mink Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mink Therapeutics is a good investment. Please check the relationship between Mink Therapeutics Other Operating Expenses and its Income Before Tax accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Mink Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.
Other Operating Expenses vs Income Before Tax
Other Operating Expenses vs Income Before Tax Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mink Therapeutics Other Operating Expenses account and Income Before Tax. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Mink Therapeutics' Other Operating Expenses and Income Before Tax is -0.59. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Income Before Tax in the same time period over historical financial statements of Mink Therapeutics, assuming nothing else is changed. The correlation between historical values of Mink Therapeutics' Other Operating Expenses and Income Before Tax is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Mink Therapeutics are associated (or correlated) with its Income Before Tax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Before Tax has no effect on the direction of Other Operating Expenses i.e., Mink Therapeutics' Other Operating Expenses and Income Before Tax go up and down completely randomly.
Correlation Coefficient | -0.59 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Mink Therapeutics. It is also known as Mink Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on Mink Therapeutics income statement and is an important metric when analyzing Mink Therapeutics profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Most indicators from Mink Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mink Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Mink Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.Selling General Administrative is likely to drop to about 5.5 M in 2024. Issuance Of Capital Stock is expected to grow at the current pace this year
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 2.4M | 253.3K | 228.0K | 216.6K | Depreciation And Amortization | 78.0K | 121.7K | 204.6K | 118.7K |
Mink Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Mink Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Mink Stock Analysis
When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.